跳至主要内容
临床试验/NCT05117918
NCT05117918已完成不适用

A Prospective Study Evaluating the Feasibility of Telemedicine Use in the Overactive Bladder Clinical Care Pathway: a Non-inferiority Study Assessing Patient Satisfaction and Progression to Third Line Overactive Bladder Therapies

University of California, Los Angeles2 个研究点 分布在 1 个国家目标入组 177 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
177
试验地点
2
主要终点
Patient Satisfaction

研究概览

简要总结

In this study, the investigators aim to validate the telemedicine paradigm as a feasible alternative to traditional in-person clinic visits for the management of overactive bladder (OAB).

详细描述

This is a single-center, prospective randomized controlled trial. The study population will consist of two primary cohorts stratified based on the method of follow-up, either traditional in-person clinic visit or telemedicine appointment. The primary outcome will be satisfaction with OAB treatment. Secondary endpoints include rate of progression to third line therapies, changes in OAB symptom scores, safety, and cost. This non-inferiority trial is designed to provide an alternative option for care delivery that may result in improved patient satisfaction and compliance, and decreased cost, time, and travel burden for patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Idiopathic overactive bladder diagnosis, both OAB wet and OAB dry

排除标准

  • Active Urinary Tract Infection (UTI)
  • Stage 3 or 4 prolapse
  • Underlying neurologic condition contributing to OAB
  • Use of catheter

结局指标

主要结局

Patient Satisfaction

时间窗: 1 year

Treatment Satisfaction Visual Analogue Scale (TS-VAS), scale scored from 0 - 100 with 100 indicating highest satisfaction

次要结局

  • PGII(1 year)
  • Incidence of Treatment-emergent adverse events (safety and tolerability)(1 year)
  • Overactive Bladder Symptoms(1 year)
  • Accumulated cost of visit to patient (Cost)(1 year)
  • Accumulated time of visit for patient (Time)(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Victor W. Nitti, MD

Professor of Urology, Chief, Division of Female Pelvic Medicine and Reconstructive Surgery

University of California, Los Angeles

研究点 (2)

Loading locations...

相似试验

Overactive Bladder Telemedicine Non-inferiority Trial | 临床试验